Morales, Primitiva A.
HRN: 27-93-85 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/14/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
10/14/2025
10/21/2025
IV
600 Mg
Q6
Cellulitis
Waiting Final Action
Indication: Prophylaxis Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes